AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Risk Factors and Outcome of Biliary Complications Following Adult Living Donor Liver Transplantation

Recruitingn/aAges 18 Years - 65 YearsAllAssiut University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Liver transplantation (LT) is a live-saving therapy for patients with complicated chronic liver diseases and acute liver failure .Even though many complications can occur after LT, biliary complications (BC) are both common and potentially severe . a prospective study and retrospective part from hospital records. Aim of the study: 1. Detect frequency, risk factors for development of biliary complications post living donor liver transplantation, types (stricture anastomotic or not, leak, biloma, stone, cholangitis etc.โ€ฆ). 2. Evaluate outcomes of different biliary complications

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Adults more than 18 y with living donor liver transplantation in Al-Rajhy liver hospital , Assiut university,Egypt Exclusion Criteria: * pediatric liver transplantation * cadaveric liver transplantation
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

2 sites
Alrajhy center for hepatobiliary disorders
Asyut, Egypt
Al-Rajhy liver hospital
Asyut, Egypt
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy